Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

AML - 327

Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

Gautam Pantwalawalkar

Poster Presenter: Gautam Pantwalawalkar

Thumbnail for Psychiatric Manifestations of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Following CAR T-Cell Therapy in Hematologic Malignancies: A Systematic Review and Meta-Analysis

CT - 328

Psychiatric Manifestations of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Following CAR T-Cell Therapy in Hematologic Malignancies: A Systematic Review and Meta-Analysis

Anwesha Gupta

Poster Presenter: Anwesha Gupta

Previous 1...23 24 25 26 27 28 29...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Ruxolitinib Dose, Treatment-Emergent Transfusion Dependence, and Survival Outcomes in Myelofibrosis: Real-World Evidence From Taiwan

MPN - 331

Ruxolitinib Dose, Treatment-Emergent Transfusion Dependence, and Survival Outcomes in Myelofibrosis: Real-World Evidence From Taiwan

Tai-Chung Tseng

Poster Presenter: Tai-Chung Tseng

Thumbnail for Trends in Non-Hodgkin Lymphoma Mortality With Concurrent Septicemia in the United States, 1999-2025: A Population-Based CDC WONDER Analysis

MCL - 332

Trends in Non-Hodgkin Lymphoma Mortality With Concurrent Septicemia in the United States, 1999-2025: A Population-Based CDC WONDER Analysis

Ragav Vikraman Thiyagarajan

Poster Presenter: Ragav Vikraman Thiyagarajan

Thumbnail for Fixed Duration Subcutaneous Mosunetuzumab had Better Practice Efficiency versus Treat-To-Progression Subcutaneous Epcoritamab in Third-Line or Later Follicular Lymphoma: An Economic Analysis

IBCL - 334

Fixed Duration Subcutaneous Mosunetuzumab had Better Practice Efficiency versus Treat-To-Progression Subcutaneous Epcoritamab in Third-Line or Later Follicular Lymphoma: An Economic Analysis

Wenny Lin

Poster Presenter: Wenny Lin

Thumbnail for Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

AML - 336

Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Comparative Cardiovascular Safety of Ibrutinib, Acalabrutinib, and Zanubrutinib: A FAERS Disproportionality Analysis

CLL - 337

Comparative Cardiovascular Safety of Ibrutinib, Acalabrutinib, and Zanubrutinib: A FAERS Disproportionality Analysis

Alexander den Boef

Poster Presenter: Alexander den Boef

Thumbnail for Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Patients With Newly Diagnosed Multiple Myeloma (NDMM): Final Analysis of Transplant-Ineligible (TIE) Patients in the Phase 3 CEPHEUS Study

MM - 338

Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Patients With Newly Diagnosed Multiple Myeloma (NDMM): Final Analysis of Transplant-Ineligible (TIE) Patients in the Phase 3 CEPHEUS Study

Saad Z Usmani

Poster Presenter: Saad Z Usmani

Thumbnail for Trends in Mortality From Hodgkin & Non-Hodgkin Lymphoma in the United States, 1999-2024: A CDC WONDER Analysis

HL - 339

Trends in Mortality From Hodgkin & Non-Hodgkin Lymphoma in the United States, 1999-2024: A CDC WONDER Analysis

Allah Dad

Poster Presenter: Allah Dad

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors